Fibrin sealants Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Fibrin sealants Market By Dosage Form (Liquid, Patch, and Powder), Application (Cardiovascular Surgery, Orthopedic Surgery, Thoracic Surgery, Neurosurgery, Dental Surgery, Wound Management, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Fibrin sealants Market Size is valued at USD 628.2 million in 2021 and is poised to grow at a significant CAGR of 7.2% over 2022–2028. Surgical bleeding is a very common phenomenon observed during complex surgeries, which can lead to the death of patients. Fibrin Sealants are used as supportive treatment in surgery to promote hemostasis, cartilage repair surgeries, or wound healing. It is a mixture of separately packaged human fibrinogen and human thrombin. The key driver of the fibrin sealant market is the increasing prevalence of invasive surgeries and traumatic injuries including cardiovascular surgery, thoracic surgery, neurosurgery, plastic & reconstructive surgery, and dental surgery. For instance, according to the latest data from the National Center for Health Statistics, 48 million surgical inpatient procedures were performed in the United States in 2009 itself. Also, the rising prevalence of blood-related disorders like hemophilia is expected to boost the fibrin sealants market growth. According to CDC, Hemophilia occurs in about 1 of every 5,000 male births. Based on a recent study that used data collected on patients receiving care in federally funded hemophilia treatment centers during the period 2012-2018, about 20,000 as many as 33,000 males in the United States are living with the disorder. Along with the prevalence of surgeries, increasing geriatric population, rising healthcare expenditure, attractive medical reimbursement policies implemented by government authorities, and government initiatives are expected to maintain the fibrin sealants market trend. Irrespective of attractive growth in the market, the high cost of fibrin sealants, and stringent regulatory requirements are the major restraints of the fibrin sealants market growth. Improved healthcare in developing countries is a suitable opportunity for the rapid growth of the global fibrin sealants market due to rising government initiatives, increasing number of hospitals, an increase in the number of surgeries, and rising healthcare awareness. The global fibrin sealants market is divided into North America, Europe, Asia Specific, Latin America, and MEA countries. North America held the major fibrin sealants market share in the year 2021 and is expected to dominate the market further in the forecasted years.

 

Recent Market Developments:

In Dec 2019, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched VISTASEAL Fibrin Sealant to help surgeons to control bleeding during surgical operations.

In Dec 2019, Johnson & Johnson’s Ethicon unit launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures.

In Sept 2020, Corza Health signed an agreement to acquire Takeda Pharmaceutical’s TachoSil Fibrin Sealant Patch for about $414.3 million

Fibrin sealants Market

MARKET SUMMARY
-
7.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.2%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Fibrin sealants Market

  • The global fibrin sealants market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global fibrin sealants market gives historical, current, and future market sizes on the basis of by dosage form, application, end user and geography.
Key Players
  • Baxter International Inc
  • Corza Medical
  • Tissuemed
  • Medtronic
  • The Medicines Company
Fibrin sealants Market Dynamics

The increasing prevalence of invasive surgeries and traumatic injuries including cardiovascular surgery, thoracic surgery, neurosurgery, plastic & reconstructive surgery, orthopedics surgeries, wound management, and dental surgery are leading the global fibrin sealants market. Cardiovascular and pulmonary diseases are more common in all surgeries. According to American Heart Association, Coronary heart disease is the most common type of heart disease, killing 382,820 people in 2020. Also, Medical Expenditure Panel Survey (MEPS) stated that heart disease cost the United States about $229 billion each year from 2017 to 2018. This includes the cost of health care services, medicines, and lost productivity due to death. Hence, an increase in the number of surgeries performed is significantly increasing which is expected to fuel the growth of the global fibrin sealants market.


North-America Got Significant Share

Fibrin sealants Market

On the basis of regions, the market share is divided into North America, Asia-pacific, Europe, and the Middle East and the African region. North America dominates the global fibrin sealants market. This is due to the increasing adoption of hemostats in surgical procedures, the rising number of cardiac surgeries, and attractive medical reimbursement policies in the USA. Asia Specific market is relatively growing at the highest CAGR owing to new market players, the rapidly developing healthcare sector, increasing geriatric population, and increasing healthcare expenditure.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The fibrin sealants market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Fibrin sealants Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The fibrin sealants market is projected to expand at a CAGR of 7.2% during the forecast period

Johnson & Johnson (Ethicon), Baxter International Inc, Corza Medical, Tissuemed, Medtronic, The Medicines Company, Integra LifeSciences Corporation

North America is the fastest-growing region for fibrin sealants market


Report

Table Of Content

1. Executive Summary
2. Global Fibrin Sealants Market Introduction
2.1. Global Fibrin Sealants Market – Taxonomy
2.2. Global Fibrin Sealants Market –Definitions
2.2.1. By Dosage Form
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global Fibrin Sealants Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Fibrin Sealants Market Dynamic Factors – Impact Analysis
3.6. Global Fibrin Sealants Market – Competition Landscape
3.7. Epidemiology
4. Global Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Fibrin Sealants Market, By Dosage Form, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Liquid
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Patch
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Powder
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Fibrin Sealants Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Cardiovascular Surgery
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Orthopedic Surgery
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Thoracic Surgery
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Neurosurgery
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Dental Surgery
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Wound Management
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Fibrin Sealants Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Fibrin Sealants Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Region, 2022-2028
9. North America Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Liquid
9.1.2. Patch
9.1.3. Powder
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Cardiovascular Surgery
9.2.2. Orthopedic Surgery
9.2.3. Thoracic Surgery
9.2.4. Neurosurgery
9.2.5. Dental Surgery
9.2.6. Wound Management
9.2.7. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Country, 2022-2028
9.6. North America Fibrin Sealants Market Dynamics – Trends
10. Europe Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Liquid
10.1.2. Patch
10.1.3. Powder
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Cardiovascular Surgery
10.2.2. Orthopedic Surgery
10.2.3. Thoracic Surgery
10.2.4. Neurosurgery
10.2.5. Dental Surgery
10.2.6. Wound Management
10.2.7. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Country, 2022-2028
10.6. Europe Fibrin Sealants Market Dynamics – Trends
11. Asia-Pacific Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Liquid
11.1.2. Patch
11.1.3. Powder
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Cardiovascular Surgery
11.2.2. Orthopedic Surgery
11.2.3. Thoracic Surgery
11.2.4. Neurosurgery
11.2.5. Dental Surgery
11.2.6. Wound Management
11.2.7. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Country, 2022-2028
11.6. Asia-Pacific Fibrin Sealants Market Dynamics – Trends
12. Latin America Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Liquid
12.1.2. Patch
12.1.3. Powder
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Cardiovascular Surgery
12.2.2. Orthopedic Surgery
12.2.3. Thoracic Surgery
12.2.4. Neurosurgery
12.2.5. Dental Surgery
12.2.6. Wound Management
12.2.7. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Country, 2022-2028
12.6. Latin America Fibrin Sealants Market Dynamics – Trends
13. Middle East and Africa Fibrin Sealants Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Liquid
13.1.2. Patch
13.1.3. Powder
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Cardiovascular Surgery
13.2.2. Orthopedic Surgery
13.2.3. Thoracic Surgery
13.2.4. Neurosurgery
13.2.5. Dental Surgery
13.2.6. Wound Management
13.2.7. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Fibrin Sealants Market – Opportunity Analysis Index, By Dosage Form, By Application, By End User, and Country, 2022-2028
13.6. MEA Fibrin Sealants Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Dosage Forms, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Johnson & Johnson (Ethicon)
14.2.2. Baxter International Inc
14.2.3. Corza Medical
14.2.4. Tissuemed
14.2.5. Medtronic
14.2.6. The Medicines Company
14.2.7. Integra LifeSciences Corporation
14.2.8. Takeda Pharmaceuticals
14.2.9. Vivostat
14.2.10. Stryker
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Johnson & Johnson (Ethicon)
  • Baxter International Inc
  • Corza Medical
  • Tissuemed
  • Medtronic
  • The Medicines Company
  • Integra LifeSciences Corporation
  • Takeda Pharmaceuticals
  • Vivostat
  • Stryker

Description

Fibrin sealants Market Size is valued at USD 628.2 million in 2021 and is poised to grow at a significant CAGR of 7.2% over 2022–2028. Surgical bleeding is a very common phenomenon observed during complex surgeries, which can lead to the death of patients. Fibrin Sealants are used as supportive treatment in surgery to promote hemostasis, cartilage repair surgeries, or wound healing. It is a mixture of separately packaged human fibrinogen and human thrombin. The key driver of the fibrin sealant market is the increasing prevalence of invasive surgeries and traumatic injuries including cardiovascular surgery, thoracic surgery, neurosurgery, plastic & reconstructive surgery, and dental surgery. For instance, according to the latest data from the National Center for Health Statistics, 48 million surgical inpatient procedures were performed in the United States in 2009 itself. Also, the rising prevalence of blood-related disorders like hemophilia is expected to boost the fibrin sealants market growth. According to CDC, Hemophilia occurs in about 1 of every 5,000 male births. Based on a recent study that used data collected on patients receiving care in federally funded hemophilia treatment centers during the period 2012-2018, about 20,000 as many as 33,000 males in the United States are living with the disorder. Along with the prevalence of surgeries, increasing geriatric population, rising healthcare expenditure, attractive medical reimbursement policies implemented by government authorities, and government initiatives are expected to maintain the fibrin sealants market trend. Irrespective of attractive growth in the market, the high cost of fibrin sealants, and stringent regulatory requirements are the major restraints of the fibrin sealants market growth. Improved healthcare in developing countries is a suitable opportunity for the rapid growth of the global fibrin sealants market due to rising government initiatives, increasing number of hospitals, an increase in the number of surgeries, and rising healthcare awareness. The global fibrin sealants market is divided into North America, Europe, Asia Specific, Latin America, and MEA countries. North America held the major fibrin sealants market share in the year 2021 and is expected to dominate the market further in the forecasted years.

 

Recent Market Developments:

In Dec 2019, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched VISTASEAL Fibrin Sealant to help surgeons to control bleeding during surgical operations.

In Dec 2019, Johnson & Johnson’s Ethicon unit launched its blood-stopping protein spray, designed to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures.

In Sept 2020, Corza Health signed an agreement to acquire Takeda Pharmaceutical’s TachoSil Fibrin Sealant Patch for about $414.3 million

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX